-
My Account
My Account
As on 01 Jul, 2022 | 04:01
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 16 | 78.50 | 79.80 | 74 |
| 60 | 77.30 | 79.90 | 600 |
| 55 | 77.25 | 80.60 | 50 |
| 100 | 77.20 | 81.00 | 210 |
| 5 | 77.05 | 81.25 | 100 |
| 3019 | Total | Total | 1538 |
Stock with good financial perrformance alongside good to expensive valuatio
| Open | 0.00 |
| Previous Close | 0.00 |
| Volume | 0.00 |
| Value (Lacs) | 0.00 |
| VWAP | 0.00 |
| Beta | 0.000.43 |
| High | 0.00 |
| Low | 0.00 |
| UC Limit | 0.00 |
| LC Limit | 0.00 |
| 52 Week High | 0.00 |
| 52 Week Low | 0.00 |
| TTM EPS | 0.00 |
| TTM PE | -- |
| Sector PE | 0.00 |
| Book Value Per Share | -- |
| P/B | -- |
| Face Value | 0.00 |
| Mkt Cap (Rs. Cr.) | 0 |
| Dividend Yield | -- |
| 20D Avg Volume | 0 |
| 20D Avg Delivery(%) | -- |
*Delayed by 20 seconds.
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
Auro Labs Standalone June 2021 Net Sales at Rs 10.53 crore, down 13.86% Y-o-Y Aug 10 2021 09:08 AM
Auro Labs Standalone June 2021 Net Sales at Rs 10.53 crore, down 13.86% Y-o-Y Aug 06 2021 10:08 AM
Auro Labs Standalone March 2021 Net Sales at Rs 13.56 crore, up 43.87% Y-o-Y Jun 23 2021 08:06 AM
Auro Labs Standalone December 2020 Net Sales at Rs 13.11 crore, up 37.35% Y-o-Y Feb 12 2021 01:02 PM
Please find enclosed herewith Compliance Certificate in terms of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended March 31, 2022, duly signed by Purva Shareregistry (India) ...  View more
Posted by : BSE/NSE Announcer
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quart...  View more
Posted by : BSE/NSE Announcer
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 41944 | Price 140.97 | % Traded 0.67 |
| Qty 67656 | Price 80.34 | % Traded 1.09 |
| Qty 100000 | Price 5.8 | % Traded 1.60 |
| Qty 100000 | Price 5.8 | % Traded 1.60 |
| Qty 200000 | Price 5.8 | % Traded 3.21 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Qty 1001 | Price 121.19 | % Traded 0.02 | Post Tnx Hold. 6.94% |
| Qty 500 | Price 121.4 | % Traded 0.01 | Post Tnx Hold. 6.93% |
| Qty 200 | Price 126.4 | % Traded 0.00 | Post Tnx Hold. 6.92% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
| Qty 1200 | Price 0 | % Traded 0.01 | Post Tnx Hold. 7.08% |
| Qty 4908 | Price 0 | % Traded 0.07 | Post Tnx Hold. 7.06% |
| Qty 1200 | Price 0 | % Traded 0.01 | Post Tnx Hold. 7.08% |
| Qty 4908 | Price 0 | % Traded 0.07 | Post Tnx Hold. 7.06% |
| Qty 1000 | Price 0 | % Traded 0.01 | Post Tnx Hold. 6.98% |
| Qty 749 | Price 0 | % Traded 0.01 | Post Tnx Hold. 6.97% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Auro Labs | 79.80 | 4.52 | 49.74 | 17.50 | 1.58 | 9.02 | -50.68 | 2 | 50 | 0.03 |
| Sun Pharma | 829.25 | -0.16 | 198,964.85 | 61.56 | 3.90 | 6.81 | 21.21 | 3,405 | 38,654 | 0.02 |
| Divis Labs | 3,637.55 | 0.20 | 96,565.52 | 32.62 | 8.23 | 25.24 | -17.99 | 2,960 | 8,959 | 0.00 |
| Cipla | 949.30 | 3.50 | 76,599.70 | 30.44 | 3.63 | 12.07 | -2.94 | 2,559 | 21,763 | 0.04 |
| Dr Reddys Labs | 4,385.90 | -0.18 | 72,999.37 | 33.45 | 3.80 | 11.35 | -21.10 | 2,112 | 21,545 | 0.17 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
